Le Lézard
Classified in: Health
Subject: FDA

Los Angeles Weight Loss Surgeon, Dr. David Davtyan, Thrilled for New FDA Approved ReShape Lifesciences® Next-Generation Lap-Band® 2.0 FLEX


The recent FDA PMA supplement approval for the next-generation Lap-Band® 2.0 FLEX marks a significant milestone. Dr. David Davtyan and his team at The Weight Loss Surgery Center of Los Angeles are looking forward to offering this innovative solution to their patients.

BEVERLY HILLS, Calif., Dec. 26, 2023 /PRNewswire-PRWeb/ -- Dr. David Davtyan, a renowned surgeon and pioneer in weight loss surgery, is delighted to announce the FDA approval of ReShape Lifesciences' groundbreaking Lap-Band® 2.0 FLEX. Dr. Davytan was one of the first surgeons in the United States to offer the Lap-Band procedure and leads The Weight Loss Surgery Center of Los Angeles, a prestigious medical weight loss clinic in Beverly Hills. Dr. Davytan has dedicated his career to helping patients battle obesity through various surgical procedures. The enhanced Lap-Band® 2.0 FLEX development effort was physician-led, including input from Dr. Davtyan, with the goal of improving the patient experience. Compared to the current Lap-Band, the Lap-Band® 2.0 has a new feature called FLEX Technology, which acts as a relief valve, allowing larger pieces of food to more easily pass through the narrowed passage created by the band. This minimizes discomfort caused by the passage of large food pieces through the stoma. The Lap-Band® system has long been considered the safest and most durable weight loss option for obese patients. It is particularly ideal for those who are opposed to medically managed weight loss and prefer an anatomy-preserving surgery. Using this latest advancement, The Weight Loss Surgery Center of Los Angeles looks forward to continuing their mission of transforming lives through cutting-edge, safe and effective weight loss procedures.

"With the introduction of the Lap-Band® 2.0 FLEX, patients can expect an even more seamless and comfortable weight loss journey," says Dr. David Davytan.

"With the introduction of the Lap-Band® 2.0 FLEX, patients can expect an even more seamless and comfortable weight loss journey," says Dr. David Davytan.

More about Dr. David Davtyan:

Dr. David Davtyan is a highly-respected weight loss surgeon with over 28 years of experience and has treated thousands of patients with exceptional results. He earned his medical degree from UCLA's School of Medicine, where he was trained to treat extremely difficult and metastatic cancer cases. He went on to study bariatric surgery in Belgium, where the Lap-Band was first introduced, and became one of the first surgeons in the United States to offer the procedure once it achieved FDA approval in April of 2001. Dr. Davtyan and his team offer top quality weight loss surgery (bariatric surgery) and treatment in Los Angeles, Orange County and the Inland Empire. For more information, please call 877-923-7546 or visit http://www.weightlosssurgeryla.com.

Media Contact

Kia, The Weight Loss Surgery Center of Los Angeles, 877-923-7546, [email protected], https://weightlosssurgeryla.com/

SOURCE The Weight Loss Surgery Center of Los Angeles


These press releases may also interest you

at 00:45
Q1 2024 Results Further strong market share gains, disciplined execution Revenues flat yoy, outperforming markets; Adecco's relative revenue growth +600 bpsBy GBU, Adecco, +1% yoy, of which APAC +14%, Southern Europe & EEMENA +8%, DACH +7%; LHH -5%,...

at 00:00
APEX Orthopedics Investments, a groundbreaking asset management company dedicated to fostering innovation in the foot and ankle orthopedic sector, announces its establishment. Led by a team of experts and located in the University of...

6 mai 2024
Remidio Inc., a health technology innovator developing cutting-edge technology to combat global blindness from Diabetic Retinopathy, Glaucoma, AMD, & Cataracts, is all set to achieve a significant milestone....

6 mai 2024
Information Mediary Corp (IMC) and Adherence have collaborated to introduce a digitized Morisky Medication Adherence Scale (MMAS), revolutionizing medication adherence management. This innovative solution signifies a significant advancement in...

6 mai 2024
Helius Medical Technologies, Inc. ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced the pricing of a public offering of 804,999 shares...

6 mai 2024
Planned Parenthood of Metropolitan Washington, DC (PPMW) recently received an Underserved Communities Projects grant from Montgomery County, Maryland, to grow the PPMW Promotoras de Salud community health outreach program. The Promotoras de Salud...



News published on and distributed by: